Oxidative stress reduction by icodextrin‐based glucose‐free solutions in peritoneal dialysis: Support for new promising approaches
Artificial Organs · 2024
DOI: 10.1111/aor.14801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, 2024. Verfasst von Anna Basso und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Nephrology, Dialysis and Transplantation Unit, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Icodextrin, Oxidative Stress, Dialysis Solutions. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Università degli Studi di Padova.
Abstract (Originalsprache)
Background
Oxidative stress (OxSt) and inflammation are common in CKD and are known CV and mortality risk factors. In peritoneal dialysis (PD) OxSt and Inflammation even increase due to the use of glucose‐based solutions. Patients and Methods This study analyzed in 15 PD patients the effect of 3 and 6 months of treatment with icodextrin‐based glucose‐free solutions on OxSt and inflammation, evaluating p22 phox protein expression (Western blot), NADPH oxidase subunit, essential for OxSt activation, MYPT‐1 phosphorylation state, marker of RhoA/Rho kinase pathway (ROCK) activity, involved in the induction of OxSt (Western blot) and Malondialdehyde (MDA) production (fluorimetric assay). Interleukin (IL)‐6 blood level (chemiluminescence assay) has been measured and used as a marker of inflammation. Results p22 phox protein expression, MYPT 1 phosphorylation, and MDA were reduced after 3 months from the start of icodextrin (1.28 ± 0.18 d.u. vs. 1.50 ± 0.19, p = 0.049; 0.89 ± 0.03 vs. 0.98 ± 0.03, p = 0.004; 4.20 ± 0.18 nmol/mL vs. 4.84 ± 0.32 nmol/mL, p = 0.045, respectively). In a subgroup of 9 patients who continued the treatment up to 6 months, MYPT‐1 phosphorylation was further reduced at 6 months compared to baseline (0.84 ± 0.06 vs. 0.99 ± 0.04, p = 0.043), while p22 phox protein expression was reduced only at 6 months versus baseline (1.03 ± 0.05 vs. 1.68 ± 0.22, p = 0.021). In this subgroup, MDA was reduced at 6 months versus baseline (4.03 ± 0.24 nmol/mL vs. 4.68 ± 0,32, p = 0.024) and also versus 3 months (4.03 ± 0.24 vs. 4.35 ± 0.21, p = 0.008). IL‐6 level although reduced both at 3 and 6 months, did not reach statistical significance.
Conclusions
The reduction of OxSt with icodextrin‐based PD solutions, although obtained in a small patients cohort and in a limited time duration study, strongly supports the rationale of using osmo‐metabolic agents‐based fluids replacing glucose‐based fluids. Ongoing studies with these agents will provide information regarding preservation of peritoneal membrane integrity, residual renal function, and reduction of CVD risk factors such as OxSt and inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Nephrology, Dialysis and Transplantation Unit, University of Padova, Padova, Italy.
ORCID-Profile: Giovanni Bertoldi, Giulia Driussi, Lorenzo A Calò
Förderung
- Università degli Studi di Padova
Zitieren
APA
Basso, A., Baldini, P., Bertoldi, G., Driussi, G., Caputo, I., Bettin, E., Cacciapuoti, M., & Calò, L. A. (2024). Oxidative stress reduction by icodextrin‐based glucose‐free solutions in peritoneal dialysis: Support for new promising approaches. Artificial Organs. https://doi.org/10.1111/aor.14801
Vancouver
Basso A, Baldini P, Bertoldi G, Driussi G, Caputo I, Bettin E, et al. Oxidative stress reduction by icodextrin‐based glucose‐free solutions in peritoneal dialysis: Support for new promising approaches. Artificial Organs. 2024. doi:10.1111/aor.14801
BibTeX
@article{Basso2024,
author = {Basso, Anna and Baldini, Paola and Bertoldi, Giovanni and Driussi, Giulia and Caputo, Ilaria and Bettin, Elisabetta and Cacciapuoti, Martina and Calò, Lorenzo A},
title = {Oxidative stress reduction by icodextrin‐based glucose‐free solutions in peritoneal dialysis: Support for new promising approaches},
journal = {Artificial Organs},
year = {2024},
doi = {10.1111/aor.14801}
}
EUVIMED